
Research presentation in London
Professor Zhihong Yang, Director of Tang IVF Clinic, presented embryo-assessment research at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology in London in July 2026. The clinic’s report describes an oral presentation examining cytoplasmic strands in euploid blastocysts selected for transfer in PGT-A cycles. The article was published in October; the conference itself took place earlier in the year.
The clinical question
Embryo selection can remain a question even after chromosome screening. More than one embryo may have a result classified as euploid, while their developmental appearance and behaviour differ. The reported study asked whether a particular morphological feature — cytoplasmic strands — could provide useful additional information when choosing between these embryos.
What the report describes
According to the clinic’s account, the team prospectively compared transfer outcomes for euploid blastocysts with and without this feature. The report describes higher clinical-pregnancy and implantation outcomes in the group with cytoplasmic strands. The comparison concerns a morphological feature within a group of euploid embryos, rather than a comparison of all IVF cycles with and without genetic screening.
Why morphology and chromosome testing are separate
PGT-A examines chromosome-number findings in sampled cells. Morphological assessment observes embryo development and appearance. These forms of information address different aspects of embryo assessment; a favourable appearance is not a chromosome diagnosis, and a euploid result does not establish that implantation will occur. The research concerns how the information might be combined, rather than replacing one test with another.
Questions for further research
The original report describes discussions with international colleagues about larger datasets, replication in different patient populations and the possible use of developmental features in AI-assisted assessment. Those are directions for additional work. Establishing how a marker performs across centres requires clear definitions, outcome measures and validation beyond a single presentation.
Connection with the clinic’s laboratory work
The presentation forms part of the clinic’s reported interest in embryo culture, time-lapse assessment and reproductive genetics. For readers interested in the techniques themselves, the laboratory and patient-information pages explain their different roles. The project connects these areas by studying how developmental observations can contribute to decisions after chromosome screening.
Dates shown are publication dates; event dates are stated in the article.
Back to clinic news